Cell Therapy Microbiology Consulting

What Cell Therapy Microbiology Consulting does

Cell Therapy Microbiology Consulting is a privately held, for-profit consulting firm founded in 2016 and headquartered in Lynden, United States. According to its firmographics profile, the company provides education, webinars, training, medical modalities, cellular therapy, and publication services — positioning it as a niche professional services provider focused on the intersection of microbiology and cell therapy. The firm operates at a very small scale, with 1-10 employees per the available data, and no management team, founder credentials, or named personnel are disclosed in the provided sources.

The business model is service-based and content-based, generating revenue through fee-for-service consulting, paid or sponsored educational programs (webinars and training), and publication-related work. No pricing models, contract structures, or revenue figures have been disclosed, and the company's website (celltherapymicro.com) returned only a verification waiting page rather than substantive content at the time of data collection. No customer logos, geographic reach beyond the United States, or technology stack details are documented.

No funding rounds, acquisitions, partnerships, certifications, patents, regulatory actions, or strategic transactions appear in the source data. The firm has no disclosed subsidiaries, no app or API offerings, no social media profiles documented, and no AI/ML capabilities referenced. As a result, the analytical depth available is limited to the firmographic-level description above, and any deeper characterization of competitive positioning, customer mix, or growth trajectory should be treated as low-confidence.

Name

Cell Therapy Microbiology Consulting

Website

https://celltherapymicro.com

Company type

Private

Founded year

2016

Headcount range

1–10 employees

Short description

Cell Therapy Microbiology Consulting is a privately held, U.S.-based (Lynden) boutique consulting firm founded in 2016 that delivers education, webinars, training, and publication services to the cell therapy and microbiology professional community.

Ownership category

akta.pro rank

Product category

Biotech Consulting Services

NAICS

Other Scientific and Technical Consulting Services (54169), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)

akta.pro secondary industry

Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ)

Keywords

• Cell therapy consulting
• Microbiology consulting
• Cellular therapy training
• Biotech medical education
• Publication services

Headquarters

HQ city

Lynden

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Core offering

Cell Therapy Microbiology Consulting provides specialized education, training, and webinars related to cell therapy, cellular therapy, and microbiology medical modalities. The firm also offers publication services supporting professionals and organizations working in the cell therapy microbiology domain. The company operates as a niche consulting practice delivering subject-matter expertise to biotech, pharmaceutical, and clinical stakeholders.

Differentiator

Problem solved

Functional benefit

Products and services

• Cell Therapy Microbiology Education Educational programs covering cell therapy, cellular therapy, and microbiology topics delivered to professionals and organizations in the biotech and pharmaceutical sectors.
• Webinars Live and online webinar sessions focused on cell therapy microbiology topics for biotech and clinical professionals.
• Training Services Specialized training programs covering medical modalities and cellular therapy for biotech, pharmaceutical, and clinical teams.
• Publication Services Publication and content services supporting professionals working in cell therapy and microbiology domains.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Broad incumbents

• Thermo Fisher Scientific (Cell Therapy Services): Global life sciences tools and services giant with cell therapy manufacturing, viral vector, and microbiology testing offerings. Comparable broad incumbent whose bundles increasingly substitute for boutique advisory work.
• Charles River Laboratories: Large CRO/CDMO with end-to-end cell and gene therapy services including microbial testing. Comparable as a broad incumbent offering overlapping microbiology and cell therapy capabilities as part of a wider portfolio.

Direct peers

• Vineti: Cell therapy orchestration and chain-of-custody software platform serving autologous and allogeneic therapy developers. Comparable because it operates squarely in the cell therapy commercialization stack that this firm advises on.
• Proventa International: Life sciences strategy and operational consulting firm. Direct peer: similar boutique consulting model serving biopharma and cell therapy clients with advisory, training, and benchmarking engagements.
• Dark Horse Consulting: Specialist cell therapy GMP and CMC consulting firm. Direct peer: same boutique model, same target audience (cell therapy developers and manufacturers), and overlapping microbiology/contamination-control subject matter.
• TrakCel: Cell and gene therapy orchestration and patient journey software. Peer because it serves the same therapy developers navigating manufacturing, compliance, and audit-readiness workflows this consultancy educates on.
• Latham BioPharm Group: Biopharmaceutical regulatory, CMC, and compliance consulting firm. Comparable because it serves overlapping cell therapy and biologics sponsors with subject-matter advisory and training services.

Emerging players

• Cognate BioServices (now part of Charles River): Cell and gene therapy CDMO with focus on autologous and allogeneic manufacturing. Emerging peer whose cell therapy CMC and microbiology services overlap with this firm's advisory remit.
• Cellares: Automated cell therapy manufacturing platform company. Comparable as an emerging player addressing cell therapy scale-up challenges that drive consulting demand in this firm's niche.

Others

• BioPlan Associates: Biopharma manufacturing and market intelligence consultancy. Adjacent peer providing research, benchmarking, and consulting to biomanufacturing organizations including cell therapy developers.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/cell-therapy-microbiology-consulting-llc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cell Therapy Microbiology Consulting